AGL 40.05 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 127.02 Decreased By ▼ -0.62 (-0.49%)
BOP 6.67 No Change ▼ 0.00 (0%)
CNERGY 4.53 Increased By ▲ 0.08 (1.8%)
DCL 8.63 Decreased By ▼ -0.10 (-1.15%)
DFML 40.70 Decreased By ▼ -0.46 (-1.12%)
DGKC 85.81 Decreased By ▼ -0.30 (-0.35%)
FCCL 33.15 Increased By ▲ 0.59 (1.81%)
FFBL 64.49 Increased By ▲ 0.11 (0.17%)
FFL 11.54 Decreased By ▼ -0.07 (-0.6%)
HUBC 111.90 Decreased By ▼ -0.56 (-0.5%)
HUMNL 15.15 Increased By ▲ 0.34 (2.3%)
KEL 5.18 Increased By ▲ 0.14 (2.78%)
KOSM 7.60 Increased By ▲ 0.24 (3.26%)
MLCF 40.58 Increased By ▲ 0.25 (0.62%)
NBP 61.26 Increased By ▲ 0.18 (0.29%)
OGDC 192.40 Decreased By ▼ -1.78 (-0.92%)
PAEL 26.81 Decreased By ▼ -0.10 (-0.37%)
PIBTL 7.43 Increased By ▲ 0.15 (2.06%)
PPL 153.45 Increased By ▲ 0.77 (0.5%)
PRL 26.38 Increased By ▲ 0.16 (0.61%)
PTC 17.20 Increased By ▲ 1.06 (6.57%)
SEARL 85.90 Increased By ▲ 0.20 (0.23%)
TELE 7.67 No Change ▼ 0.00 (0%)
TOMCL 33.85 Decreased By ▼ -2.62 (-7.18%)
TPLP 8.77 Decreased By ▼ -0.02 (-0.23%)
TREET 17.03 Increased By ▲ 0.19 (1.13%)
TRG 63.71 Increased By ▲ 0.97 (1.55%)
UNITY 27.85 Decreased By ▼ -0.35 (-1.24%)
WTL 1.31 Decreased By ▼ -0.03 (-2.24%)
BR100 10,122 Increased By 36 (0.36%)
BR30 31,253 Increased By 82.6 (0.26%)
KSE100 94,908 Increased By 144 (0.15%)
KSE30 29,438 Increased By 27.8 (0.09%)
World

UK doesn't have vaccine surplus to share

  • "Our first priority is to protect the British public, and the vaccine rollout is continuing to that end," the spokesman told reporters. "We don't currently have a surplus of vaccines, but we will consider how they are best allocated as they become available."
Published March 29, 2021

LONDON: Britain does not currently have a surplus of COVID-19 vaccines to share with other countries, but will consider how to share any future surplus if there is one, Prime Minister Boris Johnson's spokesman said on Monday

"Our first priority is to protect the British public, and the vaccine rollout is continuing to that end," the spokesman told reporters. "We don't currently have a surplus of vaccines, but we will consider how they are best allocated as they become available."

Comments

Comments are closed.